26 Countries Have Authorized the Sputnik V Vaccine

The Russian Direct Investment Fund announced the Sputnik V vaccine's approval in Montenegro, Saint Vincent, and the Grenadines. As of February 12, 2021, twenty-six countries had authorized the Sputnik V Vaccine.

These countries included Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, UAE, Iran, Republic of Guinea, Tunisia, Armenia, Mexico, Nicaragua, Republika Srpska (Bosnia and Herzegovina), Lebanon, Myanmar, Pakistan, Mongolia, Bahrain, Montenegro, Saint Vincent, and the Grenadines.

Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said in a press release, “Clinical trial data published in The Lancet medical journal on February 2, 2021, demonstrated high efficacy and safety of the vaccine."

Denis Logunov and colleagues reported interim results from a phase 3 trial of the Sputnik V vaccine showing a consistent strong protective effect across all participant age groups. Also known as Gam-COVID-Vac, the Russian vaccine uses a heterologous recombinant adenovirus approach using adenovirus 26 (Ad26) and adenovirus 5 (Ad5) as vectors for the expression of the SARS-CoV-2 coronavirus spike protein. 

Dmitriev continued saying, "Sputnik V is recognized globally as one of the key vaccines which will help protect humankind and return to normal life.”